Loading market dashboard
CanSino Biologics Inc.
CASBFHealthcareOTCCN
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
CanSino Biologics Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $2.83B | $2.74B - $2.98B | -$932.01M | $3.721 | 2 |
| Dec 2028 | $2.28B | $2.20B - $2.39B | -$748.22M | $1.251 | 1 |
| Dec 2027 | $1.82B | $1.73B - $1.95B | -$599.16M | $1.009 | 3 |
| Dec 2026 | $1.48B | $1.45B - $1.52B | -$485.13M | $0.382 | 3 |
| Dec 2025 | $1.06B | $1.02B - $1.11B | -$348.58M | $0.11 | 1 |
| Dec 2024 | $836.56M | $829.51M - $870.88M | -$275.06M | -$1.172 | 5 |
| Dec 2023 | $368.32M | $354.47M - $388.05M | -$199.12M | -$5.087 | 2 |
| Dec 2022 | $1.05B | $1.03B - $1.08B | -$569.11M | -$1.663 | 1 |
| Dec 2021 | $5.50B | $5.38B - $5.64B | -$2.98B | $10.176 | 2 |
| Dec 2020 | $11.51M | $11.25M - $11.79M | -$6.23M | -$1.658 | 2 |
| Dec 2019 | $2.26M | $2.21M - $2.31M | -$1.22M | -$0.762 | 1 |